ZNF71 and non-small cell lung carcinoma: The study used a seven-gene signature (ABCC4, CCL19, CD27, DAG1, FUT7, SLC39A8, and ZNF71 [111,112]) to accurately predict recurrence and metastasis risk across 1500 early-stage NSCLC patients, covering all histological subtypes.